Chemistry:Para-Chloroamphetamine

From HandWiki
Revision as of 22:22, 5 February 2024 by Rtextdoc (talk | contribs) (correction)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound


para-Chloroamphetamine
Para-Chloroamphetamine Structure.svg
4-CA44.jpg
Clinical data
Other namesPCA; 4-Chloroamphetamine; 4-CA
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC9H12ClN
Molar mass169.65 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

para-Chloroamphetamine (PCA), also known as 4-chloroamphetamine (4-CA), is a substituted amphetamine and monoamine releaser similar to MDMA, but with substantially higher neurotoxicity, thought to be due to the unrestrained release of both serotonin and dopamine by a metabolite.[1] It is used as a neurotoxin by neurobiologists to selectively kill serotonergic neurons for research purposes, in the same way that 6-hydroxydopamine is used to kill dopaminergic neurons.[2][3][4][5]

para-Chloroamphetamine has been detected as an apparent designer drug,[6] along with the related 3-chloroamphetamine, which is even more potent as a releaser of dopamine and serotonin but slightly less neurotoxic.[7][8][9][10][11]

The closely related N-methylated derivative, para-chloromethamphetamine (CMA), which is metabolized to para-chloroamphetamine in vivo, has neurotoxic properties as well.

Legal status

China

As of October 2015, 4-CA is a controlled substance in China.[12]

See also

References

  1. "Metabolic activation of the serotonergic neurotoxin para-chloroamphetamine to chemically reactive intermediates by hepatic and brain microsomal preparations". Biochemical Pharmacology 35 (10): 1737–1742. May 1986. doi:10.1016/0006-2952(86)90332-1. PMID 3707603. 
  2. "Effect of p-chloroamphetamine on cerebral tryptophan-5-hydroxylase in vivo: a reexamination". Neuropharmacology 14 (1): 31–39. January 1975. doi:10.1016/0028-3908(75)90063-5. PMID 125387. 
  3. "5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat". British Journal of Pharmacology 63 (4): 627–634. August 1978. doi:10.1111/j.1476-5381.1978.tb17275.x. PMID 80243. 
  4. "5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine". British Journal of Pharmacology 108 (3): 583–589. March 1993. doi:10.1111/j.1476-5381.1993.tb12846.x. PMID 7682129. 
  5. "Cerebral metabolic responses to clomipramine are greatly reduced following pretreatment with the specific serotonin neurotoxin para-chloroamphetamine (PCA). A 2-deoxyglucose study in rats". Neuropsychopharmacology 13 (3): 215–222. November 1995. doi:10.1016/0893-133X(95)00053-G. PMID 8602894. 
  6. "Detection of p-chloroamphetamine in urine samples with mass spectrometry". Journal of Analytical Toxicology 35 (4): 205–210. May 2011. doi:10.1093/anatox/35.4.205. PMID 21513613. 
  7. "Drug disposition as a factor in the lowering of brain serotonin by chloroamphetamines in the rat". Biochemical Pharmacology 21 (10): 1413–1417. May 1972. doi:10.1016/0006-2952(72)90365-6. PMID 5029422. 
  8. "Substituted amphetamine derivatives. II. Behavioural effects in mice related to monoaminergic neurones". Acta Pharmacologica et Toxicologica 41 (4): 353–368. October 1977. doi:10.1111/j.1600-0773.1977.tb02674.x. PMID 303437. 
  9. "Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum". Acta Pharmacologica et Toxicologica 44 (5): 329–335. May 1979. doi:10.1111/j.1600-0773.1979.tb02339.x. PMID 474143. 
  10. "Long-lasting reduction of brain 5-hydroxytryptamine concentration by 3-chloramphetamine and 4-chloroamphetamine in iprindole-treated rats". The Journal of Pharmacy and Pharmacology 26 (11): 912–914. November 1974. doi:10.1111/j.2042-7158.1974.tb09206.x. PMID 4156568. 
  11. "Substituted amphetamine derivatives. I. Effect on uptake and release of biogenic monoamines and on monoamine oxidase in the mouse brain". Acta Pharmacologica et Toxicologica 41 (4): 337–352. October 1977. doi:10.1111/j.1600-0773.1977.tb02673.x. PMID 579062. 
  12. "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in zh). China Food and Drug Administration. 27 September 2015. http://www.sfda.gov.cn/WS01/CL0056/130753.html.